Endoscopic Ultrasound Needles Market Competitive Growth Strategies Based on Type, Applications, End User and Region

The endoscopic ultrasound needles market is witnessing the advent of wide range of products including technological advancements in FNA and FNB for solid lesions. Endoscopic ultrasound have gained wide acceptance among surgeons as minimally invasive procedure along with EUS guided needles as the safe and minimally invasive method driving endoscopic ultrasound needles market growth.

According to the latest study by Future Market Insights (FMI), the endoscopic ultrasound needles market is expected to reach nearly US$ 405.0 million by 2025 end. Although, other methods are also viable, however, the specimens collected or diagnosis done using endoscopic ultrasound needles provides histological and cytological studies of the organ affected.

Manufacturers in the endoscopic ultrasound needles market are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with diverse portfolio is one of the key strategies of leading players. As per the report, companies in the endoscopic ultrasound needles market are also focusing on collaborating for development and distribution of advanced endoscopic ultrasound needle products. Key players in endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9247

Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases

According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for largest share in the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.

With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.

Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on endoscopic ultrasound needles market, FNB is emerging as the novel tool in diagnosis by providing information on tissue architecture.

However, FNB needles are more expensive as compared to FNA needles. Although the initial results of FNB are encouraging, more robust evidence are required to prove its superiority over FNA in endoscopic ultrasound needles market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9247

Endoscopic Ultrasound Needles to be used on a Large Scale by Ambulatory Surgical Centres

As per the study, ambulatory surgical centres will use endoscopic ultrasound needles on a large scale owing to the rise in number of these centres and increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centres. Being the minimally invasive and non-surgical procedure that can be performed through colon or upper GI tract, ambulatory surgical centers are gaining traction in the endoscopic ultrasound needles market.

Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centres with expert healthcare team. Various healthcare organisations are building ambulatory surgical centres within the premises in the healthcare facility offering wide range of services with technological advancements to achieve economies of scale. Increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the endoscopic ultrasound needles market.

According to the study, the rise in adoption of endoscopic ultrasound needles in gastroenterology is expected to accelerate the demand for enteral endoscopic ultrasound needles in the coming years.

Endoscopic Ultrasound Needles Market- Competitive Analysis

The report provides detailed profiles of the leading players in the endoscopic ultrasound needles market. Key developments and business strategies by players to remain competitive in the market are also provided in the report. Some of the key players in the endoscopic ultrasound needles market are Medtronic, Medi-globe, ACE Medical Devices Pvt. Ltd, Olympus Corporation, Cook Medical, Boston Scientific Corporation, and CONMED Corporation.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-9247

Key Segment

Based on the application

  • enteral EUS needles
  • bronchial EUS needles

Based on the Region

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Japan
  • Latin America

This FMI report also offers an accurate forecast of the endoscopic ultrasound needles market for the period between 2017 and 2025. The endoscopic ultrasound needles market is envisaged to record a CAGR of over 4.5% between 2017 and 2025. For more insights, please reach out at ress@futuremarketinsights.com

Gastroesophageal Reflux Disease (GERD) Devices Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2028

Exceeding the revenue of US$ 1 billion in 2018, the global sales of gastroesophageal disease devices will witness a steady over 4% CAGR during 2018-2028. As indicated in a new intelligence outlook of Future Market Insights (FMI), esphagoscopes and gastroscopes will continue to account for most of the sales. Adoption of gastroesophageal reflux disease devices will remain maximum for diagnostic procedures, followed by fundoplication procedures.

More Patients Continue to Prefer GERD Devices over Lifestyle Modifications & PPIs

Besides the rapid expansion of geriatric population and elevating prevalence rate of obesity-driven gastroesophageal reflux diseases, FMI in a new study states that the frequent intake of asthma medications is also a strong impact factor associated with the growth of gastroesophageal reflux disease devices market.

Although industry experts recommend lifestyle modifications as the most suitable remedy for gastroesophageal diseases, the growing demand for surgeries for obesity will continue to drive sales of gastroesophageal disease devices in coming years.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1741

Although industry experts recommend lifestyle modifications as the most suitable remedy for gastroesophageal diseases, the growing demand for surgeries for obesity will continue to drive sales of gastroesophageal disease devices in coming years.

The second line of treatment for gastroesophageal reflux disease includes proton pump inhibitors (PPI) therapy, which can reduce the usage of gastroesophageal reflux disease devices. Proton pump inhibitors are the drugs that regulate acid production within stomach, and thereby restrict gastroesophageal reflux.

However, the proven side effects and functional failure of proton pump inhibitors in the long run will continue to benefit the demand for surgical treatment of gastroesophageal reflux disease, favoring the overall sales of gastroesophageal reflux disease devices such as PH monitoring system and manometry system.

For More Information On This Report, Please Visit @ https://www.futuremarketinsights.com/checkout/1741

Diagnostic Centers & Private Clinics to Employ More GERD Devices

While a majority of adoption of gastroesophageal reflux disease devices prevails in hospitals, the constantly increasing number of establishments in the ambulatory surgical center and diagnostic center segments is likely to translate into a higher rate of adoption of gastroesophageal reflux disease devices within the latter two.

With the number of diagnostic centers and private practice clinics on the constant rise, it is more likely that the demand for gastroesophageal reflux disease devices will observe steady growth over the years to come. Towards the end of forecast period, global market value share of clinics and diagnostic centers will be more than 35%, as suggested by FMI’s analysis of the gastroesophageal reflux disease devices market.

Preview Analysis Global Gastroesophageal Reflux Diseases Devices Market: by Product Type – Diagnostic Devices, Manometry System, PH Monitoring System, Esophagoscopes and Gastroscopes, Treatment Devices, Ultrasonic Surgical Endostapler, Fundoplication Devices, Sphincter Augmentation Devices, Radiofrequency Ablation Devices; by Procedure Type – Diagnostic Procedures, Fundoplication Procedures, Radiofrequency Thermal Ablation, Magnetic Sphincter Augmentation: https://www.futuremarketinsights.com/reports/gastroesophageal-reflux-diseases-devices-market

Key GERD Device Manufacturers Eyeing New Product Launches

The report tracks some of the key companies operating in the Gastroesophageal Reflux Disease Devices market, such as Olympus Corporation, Pentax Medical, Medtronic Plc., Diversatek Inc. The report also tracks the key manufacturers operating in gastroesophageal reflux disease treatment devices, such as EndoGastric Solutions, Medigus Ltd., Torax Medical, Inc. and Mederi RF, Inc.

A majority of key manufacturers of gastroesophageal reflux disease devices are emphasizing new product launches. Innovation of new and advanced products is in turn shaping the growth of gastroesophageal reflux disease devices market.

According to the report findings,

  • Olympus Corporation and Pentax Medical hold the maximum company share in the gastroesophageal reflux disease devices market.
  • Olympus Corporation recently launched an advanced version of esophagoscope and gastroscope.
  • Plc. and Diversatek, Inc. are the key players of diagnostic devices for gastroesophageal reflux disease, contributing a significant share in overall gastroesophageal reflux disease devices market.
  • EsophyX Z is the new and advanced version of EsophyX gastroesophageal reflux disease device, used for the transoral incisionless fundoplication process.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-1741

More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

GaN-powered Chargers Market to witness a growth in revenue from US$ 694.4 Mn in 2021 to US$ 4.96 Bn by 2031

The rising demand for powerful, flexible, fast, lightweight, and highly-rated charging solutions to support power backup in smartphones & tablets, laptops & notebooks, autonomous robots, and other devices is supporting growth of GaN-powered chargers market. According to a report by Future Market Insights (FMI), the global GaN-powered chargers market is expected to surpass US$ 694.4 Mn in valuation in 2021.

 

Gallium nitride (GaN) is a high-performance alternative to the traditional silicon used in charging devices. The gallium nitride compound can minimize power loss and achieve high switching frequency with the help of characteristics such as miniaturization, high breakdown voltage because of wide band gap, and low conduction resistance.

Smartphones will remain key application for the market. It is expected to account for nearly 35% of GaN-powered chargers sold through 2021-22.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13030

Key Takeaways of GaN-powered Chargers Market Study

  • GaN-powered chargers market’s Y-o-Y growth rate is expected to improve by nearly 2% in comparison to 2020
  • The U.S. will account for dominant 85% of sales recorded in North America in 2021
  • The U.K. is expected to register solid y-o-y growth at over 13% in 2021
  • Germany, France, Russia, and Spain will be among other lucrative markets within Europe
  • While China is expected to remain dominant in East Asia, Japan will register growth at a higher rate within the market

“Key players are focusing on introduction of new solutions/products such as GaN technology and Next-Gen GaN-powered chargers for improving charging speed & system efficiency. This is expected to create lucrative prospects for growth in the coming years,” said an FMI analyst.

Disruptions Caused Due to COVID-19 Resulted in Declining Growth

The global shipments of GaN-powered chargers by power output such as 25W GaN chargers, 30W GaN chargers, 45W GaN chargers, 60W GaN chargers, and others declined in the first half of 2020 owing to supply chain disruptions caused by the COVID-19 outbreak. According to FMI, the market registered declining growth of a -1.5% as compared to the original forecast in 2019.

Increasing Value of Gallium Nitride Technology Boost Growth

Consumption of GaN-powered chargers is increasing in the consumer electronics sector Gallium nitride technology offers various benefits such as higher switching frequency, enables faster wireless power transfer, and lower system cost. These benefits are primary factors driving GaN-powered chargers market. Silicon has its physical limitation and is therefore considered less efficient in delivering the required results.

GaN has therefore emerged as a preferred technology among telecommunication vendors since it is aiding in improving efficiency of various electronic devices. This is expected to support the GaN-powered chargers market growth.

Who is Winning?

Companies operating in the market have been focusing on offering innovations to gain competitive edge. Some of them are even conducting rigorous performance, reliability, and technology checks to review the safety and efficiency of these chargers.

Some of the leading market players are Xiaomi Corporation, Koninklijke Philips N.V., Belkin International, Inc., GaN Systems Inc., RAVPower, Baseus, and among others.

More Valuable Insights on GaN-powered Chargers Market

A new market research report published by Future Market Insights (FMI) on the global GaN-powered chargers market includes global industry analysis for 2016–2020 and opportunity assessment for 2021–2031. The report provides valuable insights on the basis of power output (25W GaN chargers, 30W GaN chargers, 45W GaN chargers, 60W GaN chargers, 65W GaN chargers, 90W GaN chargers, 100W GaN chargers, and others), application (smartphones & tablets, laptops & notebooks, autonomous robots, industrial equipment, wireless charging, and others), and others across six major regions.

Ask More About This Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-13030

Key Questions Answered in the Report

  • What are the major trends impacting the GaN-powered chargers market growth?

The rising demand for fast charging speed is one of the key factors driving the GaN-powered chargers market. The advent of cost-effective GaN-powered chargers and introduction of a multitude of chnological advancements are expected to create lucrative sales opportunities in the near future.

  • What are the major challenges restricting GaN-powered chargers market?

The lack of standardization and high manufacturing cost are hampering the market growth. Also, quality concerns regarding packaging of high temperature electronics might hinder growth of the market to an extent.

  • Who are some of the leading manufacturers of GaN-powered Chargers Manufacturer?

Some of the leading companies manufacturing and providing GaN-powered chargers are Belkin International, Inc., Xiaomi Corporation, Koninklijke Philips N.V., GaN Systems Inc., RAVPower, Baseus, Anker, and others.

  • Which is the leading GaN-powered Chargers market?

GaN-powered chargers manufacturers are focusing on expanding their presence in South Asia and Pacific. Governments within this region have been taking initiative to adopt efficient power technologies to improve the performance of electronic devices. Coupled with this, increasing smartphone adoption will drive sales within the region.

Weight Loss and Obesity Management Market to reach a valuation of over US$ 4.9 Billion by 2028

The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe. According to the latest research by Future Market Insights (FMI), the global weight loss and obesity management market is anticipated to reach a valuation of over US$ 4.9 Bn, by the end of 2028. The weight loss and obesity management market is expected to expand at a steady CAGR of 5.2%, over the forecast period of 2018-2028.

Developing Regions More Prone to Obesity & Other Comorbidities

Increasing number of cases of obesity and related comorbidities will lead to the growing adoption of drugs and devices for weight loss and obesity management, which will further fuel the growth of the global weight loss and obesity management market during the forecast period.

The weight loss and obesity management market is majorly driven by the rising prevalence of obesity. The rising epidemic of obesity presents a major challenge to disease prevention across the globe. It is estimated that by 2030, 38% of the world’s adult population will be overweight and around 20% will be obese. This obesity epidemic is more prevalent in the Middle East and the Asia Pacific regions where food import is quite high. Weight loss and obesity management are helpful in the treatment of highly critical obesity and comorbidities associated with it, such as diabetes, asthma, sleep apnea, and hypertension, etc.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-411

Increasing health consciousness is also cited as an important factor boosting the revenue growth of the global weight loss and obesity management market. Sizeable consumer population in developed regional markets will particularly continue to generate high demand for weight loss and obesity management practices, according to the report. Millennial and Generation-X consumers are gradually adopting advanced aesthetic services, including weight loss and obesity management, thereby creating adequate opportunities for manufacturers of weight loss and obesity management drugs and devices.

Key Players:

  • Novo Nordisk A/S,
  • GlaxoSmithKline plc.,
  • F. Hoffmann-La Roche AG,
  • Allergan Plc,
  • Johnson & Johnson Services, Inc,
  • Medtronic plc.,
  • Vivus Inc.,
  • Eisai Co., Ltd.,
  • ReShape Lifesciences, Inc,
  • Obalon Therapeutics,
  • Aspire Bariatrics,
  • Allurion Technologies Inc.,
  • Nalpropion Pharmaceuticals, Inc., and
  • Beijing Noble Laser Technology Co., Ltd.

Key Vendors Targeting Extension of Product Portfolio

Leading companies operating in weight loss and obesity management market are majorly focusing on strengthening their product portfolio. Product line extensions help companies to launch newer products with unique features for specific indications. This results in an increased market share of companies in the highly competitive weight loss and obesity management market. In response to increasing demand from various healthcare professionals to effectively treat obesity with minimum long-term side effects, manufacturers are focusing on developing innovative and specific products.

Product innovation is expected to boost revenue and volume growth of the weight loss and obesity management market during the forecast period. For instance, an additional FDA patents approval for VIVUS, Inc.’s Qsymia, for the covering compositions of Qsymia and covering methods for effecting weight loss using Qsymia (phentermine and topiramate).

However, the high cost involved in research and development of obesity drugs is a great challenge for the growth of the weight loss and obesity management market. Additionally, long gestation time required for research and developmental activities as well as the need for a number of essential clinical trials to test drugs adds up to significant expenditure. The limitations posed by high development cost of anti-obesity drugs might hinder the growth of the global weight loss and obesity management market. Moreover, the high cost of surgical procedures, such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and gastric balloon treatment, may also affect the growth of the global weight loss and obesity management market adversely.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-411

The global weight loss and obesity management market is estimated based on product type, and distribution sales. Based on product type, the weight loss and obesity management market has been segmented into drugs and devices.

Drugs product type segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, a combination drug, and others. Devices product type segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems.

Devices segment is expected to hold maximum market share in the global weight loss and obesity management market. Based on distribution sales, the weight loss and obesity management market has been segmented into institutional sales and retail sales. In terms of revenue, institutional sales dominated the global weight loss and obesity management market in 2017.

Additional Questions Answered

Some of the additional questions addressed in this report on the weight loss and obesity management market-

  • What is the revenue potential of the weight loss and obesity management market across the regions of emerging economies?
  • Who are the key competitors in the weight loss and obesity management market and what are their portfolios?
  • What are the major challenges influencing the growth of the weight loss and obesity management market?

Segmentation

On the basis of product type

  • drugs
  • devices

On the basis of distribution sales

  • institutional sales
  • retail sales

On the basis of geographical

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)
  • emerging countries like China, Brazil, and India.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-411

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Marine Communication Market is expected to surpass US$ 8.6 billion in 2031

Growing focus on seamless and secure marine communication systems will propel innovation in the ensuing decade 2021-2031, with sales set to post strong gains in 2021, according to a latest study by Future Market Insights (FMI). The study tracks marine communication growth in high-growth markets, analyzing lucrative segments and strategies of key players.

The global marine communication market is estimated to register a CAGR of 7.8% during the forecast period of 2021-2031.

Key Takeaways

  • Maritime sat phone & internet devices segment is estimated to register a CAGR of 10.9% during the forecast period
  • Merchant ships segment will remain lucrative with a market share of 40.4% followed by fishing boats/vessels segment.
  • The rise in popularity of recreational boating is expected to increase the adoption of marine communication systems.
  • South Asia & Pacific marine communication market is set to register high CAGR, owing to the increasing demand of maritime digital data services in the region.

“With the advancement in digital data services, marine communication service vendors need to make numerous updates into their pre-existing communication technologies, in order to upgrade the industry and ensure maximum productivity” says FMI Analyst.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13029  

COVID-19 Impact Analysis

The effects of the coronavirus Covid-19 outbreak will extend well beyond health and the threat to human lives. There are already signs that the virus will significantly impact international trade and the shipping industry.

The epidemic has caused the shipping and maritime industry to face the worst circumstances as the workforce in these sectors has been shut down for the safety and prevention of the escalation of COVID-19. The market disruptions due to the coronavirus pandemic has resulted in 5%-7% Year on Year (YoY) decrease in annual maritime communication equipment’s in 2020.

However, amid the pandemic, various governments globally has continued to focus on developing and innovating marine communication technologies by launching advanced marine communication satellites for faster and reliable data transfer between shores and ships. For instance, on September 2020, China has launched its 3rd maritime satellite into space to carry out high-precision maritime environment monitoring. Thus, the continued innovation in maritime communication technologies has resulted in significant growth in the market.

Increasing Demand for VHF-based Data Exchange System

The VHF-based Data Exchange System (VDES) provides a robust and globally standard communication system for e-navigation. It supports the safety and efficiency of ship and shore operations. The reduced cost of deployment and improved communication is creating demand in various countries around the globe.

Moreover, marine electronic vendors are also focusing on offering cost-effective satellite-based communication. For instance, EGNOS, a European satellite-based augmentation service (SBAS), provides correction to GPS signals to increase the accuracy of position information. Thus, the demand for satellite-based communication system is driving the demand, and is fuelling the global marine communication market.

More Valuable Insights on Marine Communication Market

FMI’s report on the marine communication market is segmented into four major sections such as product (marine radio devices (fixed-mount VHF marine radios, handheld marine VHF radios, MF/HF radios), Marine Multifunction Displays (MFDs), Automatic Identification Systems (AIS) (AIS transponders, AIS receivers), Vessel Monitoring System (VMS) Terminals, Marine Radars, VHF Data Exchange System (VDES), maritime sat phone & internet devices, others) services (consulting services, integration & installation services, and after-sales support & maintenance services), application (fishing boats/vessels, merchant ships, recreational vessels, working vessels, and others), and region (North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa) to help readers understand and lucrative evaluate opportunities in the marine communication market.

Ask More About This Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-13029

Key questions answered in the report

  • How will Marine Communication market expand until 2031?

FMI projects the global marine communication market to register a CAGR worth 7.8% across the 2021-2031 assessment period. Increasing demand for high-quality communication in maritime industry is expected to drive the growth in a positive direction.

  • Which is the most lucrative market for marine communication?

US is the most lucrative region in the global marine communication market and the trend is likely to continue until the near future. This region is growing due to continuous developments in satellite-based communication systems and increased demand for enriched content from seafarers, crew and passengers in this region.

  • Who are the leading players in marine communication market?

Prominent players operating in the global marine communication landscape include Icom Inc, Inmarsat, Furuno Electric Co., Ltd., Garmin Ltd., and among others

Dental Hygiene Devices Market Insights, Deep Analysis of Key Vendor in the Industry 2022-2028

Prominently operated by Colgate-Palmolive Company, Glaxo Smith Kline plc, Johnson & Johnson, P&G, Unilever plc, and Dentsply Sirona, the dental hygiene devices landscape is currently witnessing dominance of toothbrush sales. In recent years, the dramatic growth of the E-commerce sector is translating into elevating online sales of dental hygiene devices, which is posing strong competition facing the retail pharmacy segment.

Toothbrush Records Highest Sale, Online Retail Firms up

A recent market research study by Future Market Insights provides exclusive insights on the current and prospective performance of global dental hygiene devices market, in terms of sales volume as well as revenue.

“The report categorizes dental hygiene devices landscape into the toothbrush, scalers, polishing devices, and others on the basis of product type. Toothbrush has been the top-selling product in global dental hygiene devices landscape, attributed to widespread availability, extensive selection range, broad price range, and frequent innovation,” explains a senior research analyst at FMI.

Currently, toothbrush sales account for almost 60% of the total market revenue, whereas the report indicates that dental scalers and dental polishing devices are gradually gaining ground. The study projects over 5% year over year revenue growth for the latter two in 2019 and ahead.

Retail pharmacies will remain the largest revenue generating channel of distribution in dental hygiene devices market. Whereas, online pharmacies are slated to present promising investment opportunities to dental hygiene devices manufacturers. The report projects that revenue generated through online retail would cross the US$ 1 billion mark in the next 3-4 years.

To remain ‘ahead’ of your competitors, request for a sample 

Key Players :

Colgate-Palmolive Company

The Procter & Gamble Company

Koninklijke Philips N.V.

Unilever plc.

Glaxosmithkline plc

Ultradent Products Inc.

Johnson & Johnson

3M Company

Dabur India Ltd.

Dentsply Sirona.

Key Dynamics Prompt at Rising Oral Care Concerns

The global dental hygiene devices market is low-value high-volume landscape, which remains the key factor that dampens investment. While baby boomers have been referred to as the primary consumers of dental hygiene devices, a growing percentage of juvenile and millennial people afflicted with one or more oral health problems points to the widening prospects of dental hygiene devices in coming years.

Increasing dental disease prevalence, coupled with the increasingly sophisticating infrastructure of dental care across developing regions, is predominantly responsible for improving the scope of dental hygiene devices penetration. Dental caries, periodontal conditions, and oral cancer mark some of the most significant concerns related to oral healthcare, among the population.

Asian Economies Create an Attractive Investment Pocket

The report sheds light on all the aspects related to worldwide demand for dental hygiene devices and offers insights on the growth prospects projected for global dental hygiene devices market through the next few years. The report forecasts steady yet moderate yearly revenue growth of 4.7% in 2019, and around 1/3rd of the total market value is poised to be accounted for by the Asia Pacific. North America and Western Europe are likely to hold a collective share of more than a third of the global market value.

APAC and Latin America are poised to remain highly lucrative regional markets for manufacturers of dental hygiene devices owing to consistently increasing demand for dental treatments in these regions.

Although the widening patient pool is driving the steady demand for dental hygiene devices, a sizeable population based in developing countries is still undiagnosed and untreated. FMI research points to the presence of several untapped opportunities in a massive untreated population and thereby highlights high attractiveness of emerging regional markets for dental hygiene devices manufacturers.

Besides frequent product innovations, key players in the global dental hygiene devices market maintain their strategic focus on the enhancement of distribution channel by strengthening existing marketing efforts across Asian markets, particularly in India, Singapore, and Malaysia.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8177

Toothpaste Innovations Account for a Trending Wave

The report suggests that strategic collaborations, new product launches, and geographical expansion remain the highlights of developmental strategies adopted by key companies operating in dental hygiene devices landscape. Electric/battery-operated toothbrush innovations continue to shape new launch strategies of a majority of companies, whereas most of the market leaders are focusing on introducing novel toothpaste ranges specific to various oral care demands.

GSK recently unveiled a range of Aquafresh Advance specifically for 9-12 years olds’ demographic, targeting enamel protection and cavity prevention. The company’s Consumer Healthcare arm also launched a new Sensodyne Rapid Relief range in the US. P&G also released a new toothpaste range recently, specifically for improved gum health. Dabur India Ltd. launched a modern variant of their flagship toothpaste range i.e. ayurvedic specialist toothpaste in gel format.For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/8177

Segmentation

The report offers a comprehensive taxonomy of dental hygiene devices market based on product type, distribution channels and region.

The product type segment of the dental hygiene devices market includes tooth brush, dental polishing devices, dental scalers and other dental devices. The distribution channel segment of the dental hygiene devices market includes hospital pharmacies, retail pharmacies, and online pharmacies. The dental hygiene devices market has been analyzed across regions of North America, Latin America, Europe, Asia Pacific and MEA.

Hydrocephalus Shunt Market : Notable Developments & Geographical Outlook 2022 to 2028

Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls. Increasing focus on developing such smart shunt technology, is anticipated to prove favorable for the hydrocephalus shunt market—showcasing an otherwise sluggish landscape through the forecast period of 2018-2028, as per FMI’s analysis.

The research intelligence report offers a deep-dive view of the global hydrocephalus shunt market—predicted to expand at a rather sluggish rate of 2.3 percent, reaching a valuation of US$ 498.6 Mn in 2020.

To remain ‘ahead’ of your competitors, request for a sample 

“Stringent regulatory policies is a key factor severely impacting the growth of hydrocephalus shunt market. In addition, mechanical risks including leaks, migration, obstruction, and discontinuity and biological complications including infection, abscess, pseudocyst, heamotoma, and peritonitis associated with shunt implants, is also a key factor contributing to the market’s slow-moving growth. Other contributing factors could include high surgery costs and shortage of trained neurologist—specifically reported in countries like Australia, Canada, Ireland, U.K, and New”, explains a senior analyst from the Healthcare domain. The analyst further explains that shunt blockage and malfunction are two common complication associated with stunt implants—blockages occurring in nearly 31 percent patients. Moreover, such risks and complications often result in a number of hydrocephalus shunt revision surgeries, further creating a notable demand for hydrocephalus shunt.

Competitive Landscape

This section of the report features profiles of the key players operating in the hydrocephalus shunt market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include

Medtronic Plc.,

Braun Melsungen AG,

Integra LifeSciences Corporation,

Natus Medical Incorporated,

Tokibo Co., Ltd. (Sophysa SA),

Christoph Miethke GmbH & Co. KG, among others.

Many companies in the hydrocephalus shunt market are aiming on development of smart shunt technology and to gain FDA approvals. The manufacture are mainly focusing on acquisition and collaboration activities to expand their product portfolio in the hydrocephalus shunt market. Since 1999, Aesculap division of B. Braun Melsungen AG and Christoph Miethke GmbH & Co. KG have been working together to develop and sale hydrocephalus shunts.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-7756

FMI offers key insights on the global hydrocephalus shunt market

Hydrocephalus valves segment is expected to hold a massive value share of nearly 85 percent.

Within the Hydrocephalus valves type, adjustable pressure valves is likely to witness maximum adoption in hydrocephalus shunt surgeries.

Highest growth potential exists in North America, with an attractiveness index of 2.6 during the forecast period. Such adoption trend is expected to be followed in Western Europe—the second most lucrative market, showcasing interesting profit possibilities.

By age group, pediatrics and infants segment will report maximum adoption of hydrocephalus shunt.

Ventriculoperitoneal will remain the most preferred procedure, pushing maximum revenue in the global hydrocephalus shunt.

Key Market Influencers: Technological Advancements and Awareness Campaigns for Hydrocephalus

Considering the complexity of hydrocephalus shunting along with adjustments of cerebrospinal fluid draining, manufacturers of hydrocephalus shunts are increasingly introducing programmable and anti-siphon shunt valves—aimed at regulating drainage pressure and flow. The new technologies are indicated to eliminate the need for surgery revisions as a result of complications. The cerebrospinal fluid management technologies are likely to witness increased adoption in the coming years considering its utility in reducing siphon effect over cerebrospinal fluid drainage. Programmable pressure valves are gaining prominence versus fix pressure valves owing to its external features using specialized magnetic devices that helps in modifying opening pressure of valves.

Additionally, demand for hydrocephalus shunts is slated to increase given the increasing number of government and private initiatives to spread awareness vis-à-vis hydrocephalus. Hydrocephalus Association, for instance, and its focus to conduct more hydrocephalus awareness campaigns and programs, with increased investments in research initiatives targeted at improving cure and treatment avenues for Hydrocephalus. Through its campaign ‘Roadmap to a Cure’, the organization, by 2020 is expected to invest US$20 and drive more research and support associated with hydrocephalus.

In the highly consolidated hydrocephalus shunt market,

product and pricing power lies in the hand of top three players—reigning over nearly 84 percent of the total revenue share in the global hydrocephalus shunt market. Contributing nearly US$ 389 Million, the top three players include Medtronic Plc., Integra LifeSciences Corporation, and B. Braun Melsungen AG. Key forward market strategies include- viz. Efforts to gain regulatory approvals, geographic expansions in emerging economies, production capacity expansion, increased investments in R&D, and acquisitions to solidify global position in neurosurgery and regenerative technologies. Strategic collaborations in the form of mergers and acquisitions, is expected to bring significant growth opportunities for the three leading players, predicts FMI in its hydrocephalus shunt market report.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7756

Segmentation

The report offers a comprehensive taxonomy of the hydrocephalus shunt market based on product type, procedure type, age group and region. By product type, the hydrocephalus shunt market is segmented into hydrocephalus valves and hydrocephalus catheters. Hydrocephalus valve segment is further sub-segmented into fix pressure valves and adjustable pressure valves. Hydrocephalus catheters segment is further sub-segmented into standard catheters and antimicrobial catheters.

By procedure type, the hydrocephalus shunt market is segmented into

ventriculoperitoneal

ventriculoatrial

lumboperitoneal

ventriculopleural.

By age group, the hydrocephalus shunt market is segmented into pediatric and adult segment.

The hydrocephalus shunt market has been analyzed across eight regions including

North America,

Latin America,

Europe,

Asia Pacific Excluding China & Japan,

China,

Japan, and MEA.

Gynaecological Examination Chairs Market 2022 Industry Research, Segmentation, Key Players Analysis and Forecast to 2028

With the growing income of people across the globe, they are willing to pay more for healthcare, the revenue being generated by hospitals is also increasing rapidly. Hospitals and various healthcare facilities are also increasing their spending to enhance the quality of services and their equipment. The proliferating healthcare expenditure is expected to positively impact the gynaecological examination chairs market.

As a result of the growing demand and expenditure of the consumers, companies are also gearing up in order to take leverage of the arising opportunities and to stay competent in the market. They are strengthening product portfolio by launching novel products with advanced features through product development and acquisitions and mergers. The companies are also concentrating on developing a strong distribution channel and supplier chain in order to expand their presence in the emerging and untapped markets. For instance, in May 2017, Oakworks Inc. announced the introduction of STUDIO, a table designing solution that provides clients with complete flexibility when designing products. Along this line in the same time, the company completed the collaboration with FAMED Medical Solutions. Due to collaboration the company introduce novel iNSPIRITMedical Solutions.

To remain ‘ahead’ of your competitors, request for a sample 

According to a report published by Future Market Insights (FMI), the global gynaecological examination chairs market is expected to witness a CAGR of 6.9% from 2018 to 2028. The market was worth US$ 408.4 Mn in 2017 and is projected to rise to a valuation of US$ 852.3 Mn by the end of 2028.

Advances in Technology to Have a Positive Impact on the Market

The healthcare industry around the globe is booming exponentially. Heavy investments are made in the healthcare industry, especially in the hospital and clinics sectors. The demand for technologically advanced products is increasing among practitioners and physicians for reducing operating and examination time. Adoption of technologically advanced chairs powered by foot switches and remote will be beneficial in adjusting the required height. These advance features provide efficiency in examination. Gynaecologists across the globe are adopting advanced gynaecological chairs that are compatible with video colposcopy device holders, organic waste containers and are made of antimicrobial materials in order to reduce the time and manpower required to manage all the adjustments.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6750

Strict Regulations to Act as a Prime Roadblock in Market Growth

The companies in the market are facing strict regulatory policies in the development of new products for medical furniture, such as examination chairs and tables. The manufactured products should meet the standards of the U.S. Access Board Proposed Standards for Accessible Medical Diagnostic Equipment. Most of the companies are facing difficulties in bringing gynaecology examination chairs to the market without greater predictability and transparency from FDA. The products have to meet the standard of sterilization and environment protection regulation.

Parent Indicators Healthcare

Current expenditure on health, % of gross domestic product

Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

Annual growth rate of current expenditure on health, per capita, in real terms

Out-of-pocket expenditure, % of current expenditure on health

Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

Physicians, Density per 1000 population (head counts)

Nurses, Density per 1000 population (head counts)

Total hospital beds, per 1000 population

Curative (acute) care beds, per 1000 population

Medical technology, Magnetic Resonance Imaging units, total, per million population

Medical technology, Computed Tomography scanners, total, per million population

Market Taxonomy

The global gynaecological examination chairs market has been segmented into:

Product Type

Non-electric gynaecological Examination Chairs

Electric gynaecological Examination Chairs

Price Range

Premium

Medium

Low-price

End User

Hospitals

Obstetrics & Gynaecology Clinics

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6750

Region

North America

Western Europe

Eastern Europe

Latin America

Asia Pacific Excl. China & Japan

(APECJ)

China

Japan

Middle East and Africa

Instrument Cleaners and Detergents Market 2022 Key Players, End User, Demand and Consumption by 2031

Increase in incidence of hospital-acquired infections is enabling growth in the instrument cleaners and detergents market, which is expected to reach US$ 2.02 Bn in 2021. The market is projected to register growth at a positive pace between 2021 and 2031, driven by the increasing occurrence of hospital-acquired infections (HAIs).

Hospital-acquired infections have emerged as a key health concern, influencing patient recovery that has a significant effect on mortality recorded worldwide. In addition, the increase in the occurrence of surgical site infections is expected to drive the market.

Hospitals utilize various medical instruments during the course of treatment and diagnosis of the patients. These medical instruments ought to be disinfected and cleaned on daily basis which requires the detergents and cleaners.

Apart from this, rising cases of chronic diseases, growing overall population, and improving medical care awareness among general people are some of the primary reasons driving the instrument cleaners and detergents market.

To remain ‘ahead’ of your competitors, request for a sample

Spurred by favorable trends, some of the leading pharmaceutical companies are focusing on expanding their product scope across various distribution channels. Currently, the market can be broadly categorized into cleaners and detergents in terms of products. Of these, detergents are forecast to account for over 73% of sales in the market by 2031.

Rising demand from hospitals and various other healthcare institutions will remain a chief growth driver. Amid COVID-19 outbreak, focus on sanitization is at all-time high. This has caused the sales of instrument cleaners and detergents to soar as well.

Key Takeaways from Instrument Cleaners and Detergents Market Study

Instrument cleaners and detergents market will register 4.1% CAGR between 2021 and 2031, thanks to higher focus on curbing the incidence of infection in healthcare institutions

Demand from hospitals will continue rising. Hospitals are likely to emerge as dominant end user and reach a market value of US$ 1.1 Bn by 2031

The U.S. is the most lucrative market in the global instrument cleaners and detergents market and is expected to grow at a CAGR of 4.4% between 2021 and 2031

After a period of positive growth, the demand will drop slightly in the U.K. In 2021, the U.K. market is expected to register 3.7% y-o-y growth

China and Japan are likely to dominate sales registered in East Asia

“Expansion of the healthcare sector globally, increasing cases of hospital acquired infections, rise in the prevalence of surgical site infections, and increasing investments by governments to improve healthcare infrastructure will present a conducive environment for increasing sales of instrument cleaners and detergents,” says the FMI Analyst

Key Participant Insights

The instrument cleaners and detergents market is set to expand in the forecast period, as a result of rising prevalence of various infectious diseases, and growing investment in R&D. Some of the leading companies are actively engaging into acquisitions and expansion in order to enhance their product portfolio and outreach.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-10828

Key Market Players Covered By FMI Include:

Metrex Research

LLC , Ruhof Corporation

Case Medical, Inc.

Certol International LLC

Dr. Weigert, Biotrol

ORO Clean Chemie AG

Medalkan

STERIS Plc

Getinge Group

Ecolab Inc.

3M Co.

Cantel Medical Corporation

EQT (Schülke & Mayr GmbH)

Fortive Corporation (Advanced Sterilization Products)

Medline Industries, Inc.

Who is Winning?

Some of the leading players operating in the market are concentrating on rising acquisitions at territorial levels. The pattern is mainly seen across Europe and North America. Acquisitions offer organizations the scope to expand portfolio. It is therefore one of the key strategies adopted by the market players to strengthen their footprint. For instance:

In, January 2021, STERIS Plc and Cantel Medical Corp  announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary.  Cantel is a global provider of infection-prevention products and services, primarily to endoscopy and dental Customers.

In December 2020, CANTEL MEDICAL CORP. and Censis Technologies announced a new long-term partnership to combine Cantel’s leading infection-prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

Instrument Cleaners and Detergents Market by Category

By Product Type:

CleanersLiquid Solutions

Foam-based Cleaners

Gel-based Cleaners

DetergentsEnzymatic Detergents

Neutral Detergents

Acidic Detergents

Alkaline Detergents

By Process Type:

Presoak

Manual cleaning

Automatic Cleaning

Disinfection

By Instrument Type:

Surgical instruments

Endoscopes

Ultrasound

Dental Instruments

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-10828

By End User:

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Specialty Clinics

Others

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

Gastric Electric Stimulators Market 2022 Key Players, SWOT Analysis, Key Indicators and Forecast to 2026

The worldwide uptake of gastric electric stimulators is anticipated to witness hefty demand in 2019, representing a rigorous 6.6% y-o-y growth, while reaching a valuation of approx. US$ 188.4 Million in 2026. As per Future Market Insights (FMI) report on gastric electric stimulators market for the forecast period 2018–2026, gastric electric stimulators’ demand is anticipated to be accelerated by a host of pacesetters.

The FMI report on gastric electric stimulators market opines that sales of gastric electric stimulators are likely to witness sheer proliferation in coming time, on the back of burgeoning minimally invasive procedures, surging reported cases of gastroparesis, and encouraging reimbursement schemes. Growing pervasiveness of gastroparesis has been identified as the primary demand generating factor making gastric electric stimulators highly preferred treatment substitute for such arduous diseases.

“Enterra system, a critical medical device which is highly used to treat Gastroparesis has received FDA approval as a humanitarian use device, on the back of its potential to treat or diagnose a disease or condition affecting approx. 4000 individuals annually in the United States. Though conditionally, the American College of Gastroenterology (ACG) also recommends adoption of gastric electric stimulators for individuals with chronic, stubborn nausea and vomiting caused by Gastroparesis. The gastric electric stimulators, like Enterra, is a battery-based gastric neurostimulator, which is usually rooted under the skin in lower abdomen part of the body”, Senior Analyst, FMI.

“To remain ‘ahead’ of your competitors, request for a sample”

As per the FMI report on gastric electric stimulators market, considering the rareness of Gastroparesis in tandem with the widespread occurrence of gastric-related issues, investments in R&D and clinical studies have considerably increased in the recent past. Moreover, the growing adoption of gastric electric stimulators as an effective substitute to gastrectomy in patients with end-stage gastric dysfunction, is projected to accelerate the demand for gastric electric stimulators considerably by the end of 2026.

High-Frequency Product Type Gaining Colossal Traction

According to the FMI report, high-frequency variant of gastric electric stimulators are witnessing mammoth traction as being one of the most compelling product type, in comparison to the low-frequency variant of gastric electric stimulators. The FMI gastric electric stimulators market report opines that high-frequency variant of gastric electric stimulators aren’t just minimally invasive and extremely patient-friendly in terms of insertion, but also encompass comparatively longer battery life than the low-frequency variant of gastric electric stimulators. Additionally, as per FMI analysis, with over 75% gastric stimulators market share, high-frequency variant of gastric electric stimulators is likely to ameliorate the Gastroparetic treatment landscape.

Though, gastric electrical stimulation makes the most viable treatment option for chronic drug-refractory nausea and vomiting peripheral to Gastroparesis of idiopathic or diabetic etiology, Enterra Therapy associated risks remain exceptionally high, thereby hampering the adoption of gastric electric stimulators.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8992

Gastric Electric Stimulators Market- Competitive Dashboard

Some of the key manufacturing companies operating in the gastric electric stimulators market space include:

ReShape Lifesciences, Inc.,

IntraPace Inc.,

Changzhou Ruishen Medical Equipment Co., Ltd,

Medtronic Plc., and others.

The key players have been featured in the report based on multiple factors, including differential strategies, advertising approaches, product offerings, geographical presence, and key focus areas. The leading manufacturers operating in the global gastric electric stimulators market will continue to focus on commercializing technologically advanced products with enhanced functionality and reliability.

North America Gastric Electric Stimulators Market Remains Lucrative FMI gastric electric stimulators report opines that North America is likely to retain its dominance in the gastric electric stimulators market between 2018 and 2026. According to the FMI report on gastric electric stimulators market, growing investments in medical studies and R&D activities, continuing technical advancements and innovations, coupled with the presence of several leading market players, are other key factors paving way for lucrative opportunities in across North America gastric electric stimulators market. According to gastric electric stimulators market report, the worldwide gastric electric stimulators market will continue to remain highly consolidated with market Mughals contributing approx. 5o% revenue share to global gastric electric stimulators market, owing to their superior product offering and extensive demographic presence. Further, to capitalize on the growing demand for gastric electric stimulators, leading market players are poised to indulge into collaborations and acquisitions of local players, to reinforce their market presence.

Key Segment Based on Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8992

Based on Product Type

high frequency gastric electric stimulators devices

low frequency gastric electric stimulators devices

Based on Indication

refractory nausea

gastroparesis

obesity